Philip Hemme, Author at Labiotech.eu

About

Young French-German Entrepreneur, Co-founder & CEO of Labiotech.eu. High-level table tennis player, and German beer/French Wine lover 🙂

Articles by Philip Hemme

metamorphosis biopharmceutical innovation bio europe spring 2015

News and Trends 26 Mar 2015

The Metamorphosis of Biopharmaceutical Innovation #BIO-Europe2015

Innovation can occur in many different ways, and biopharmaceutical innovation is no exception. The pipelines of big Pharmas have fewer candidates, R&D costs are skyrocketing, internal research programs tend to shrink and open innovation is raising. This metamorphosis is happening right now and the plenary session of Bio-Europe Spring 2015 focused on this subject. A great opportunity […]

March 26, 2015 - 6 minutesmins - By Philip Hemme

microbiome microbiomics seventure partners

News and Trends 19 Mar 2015

The World’s First €100M Microbiome-focused Venture Fund opened in France

Microbiomics is one of the next big trends in the Biotech industry. Using bacteria present in our guts to cure people has shown more and more potential. The VC industry is now interested in this field. Seventure Partners, the second largest Biotech Venture capital company and the world’s first €100M fund focused on Microbiome is now opening in […]

March 19, 2015 - 3 minutesmins - By Philip Hemme

News and Trends 12 Mar 2015

Sanofi and its Succesful Pivot from Chemistry to Biotechnology [BIO-Spring 2015]

Sanofi is France’s largest pharma company and the 3rd biggest in the World. The VIP guest of BIO-Europe Spring was Serge Weinberg, Chairman and temporary CEO of Sanofi. You might have been expecting a boring corporate conference with a strong Frenchy-accent English but actually, the talk was extremely clear and interesting. Weinberg went through Sanofi’s innovation strategy as […]

March 12, 2015 - 4 minutesmins - By Philip Hemme

News and Trends 10 Mar 2015

Live from Bio-Europe 2015: The product development challenges in the gene therapy field

Gene Therapy is really the hot topic right now in the field of Biotech especially with technologies such as CRISPR and CAR-T therapies. The value of such companies are skyrocketing and many see the field as the next potential blockbuster therapies. Gene therapy has clearly a huge potential but also lot of challenges, let’s go through […]

March 10, 2015 - 3 minutesmins - By Philip Hemme

News and Trends 4 Feb 2015

And now, Moderna signs a strategic partnership with prestigious Institut Pasteur

Moderna is the Biotech company that raised the biggest VC round ever ($450M) and which signs deals almost every week. It signed a $50M deal with Merck two weeks ago, and now signs a strategic partnership with prestigious Institut Pasteur from Paris through its new Venture Valera. Moderna is developing a proprietary mRNA therapeutics platform. Instead […]

February 4, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 26 Jan 2015

Is Gecko’s Bio-inspired Glue going to revolutionize Heart Surgery and Tissue Repair?

Imagine you could use a glue to fix a hole or week zone inside your body. Sound promising? Definitely. A new generation of adhesive has been discovered. It can be used in a highly challenging environment and be activated by light. The illustration below shows you how it could be used in heart surgery. The […]

January 26, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 20 Jan 2015

Will Microalgaes solve the Rare Earth conflict?

The extraction of rare earths is a very expensive process, having dramatic consequences for the planet (degradation, impacts on water quality, etc.). Currently, China controls 95% of the World production of these minerals widely used in the field of new technologies and electronics. The development of new methods of sustainable recycling from waste and environmentally friendly is […]

January 20, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 17 Jan 2015

Qiagen, the new giant in next-gen sequencing tools?

Yet again, a new acquisition in this beginning of 2015. Enzymatics, the Boston-area based Biotech company and leading provider of enzymes for Next-gen sequencing, has been acquired by Qiagen for a non-disclosed amount. The amount must be pretty high since Enzymatics’ enzymes are used in 80% of all NGS reactions and the company counts over 150 employees. […]

January 17, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 13 Jan 2015

Roche spent $1B for the Leading Molecular Information Biotech company: Foundation Medicine

2015 starts in a rush for the Biotech industry. Swiss Pharma-giant Roche just announced paying $1B to acquire 56% percent of leading molecular information and genomic analysis Biotech company Foundation Medicine. Foundation Medicine is a leading Biotech company in the field of molecular information and genomic analysis. It uses next-gen sequencing technology and solid bioinformatic analysis […]

January 13, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 9 Jan 2015

Will Nestlé lead the promising microbiome industry?

Nestlé is one of the food giants in the World. Last Tuesday, it made a huge step in the microbiome industry by investing $65M in Boston-based Seres Health, one of the most advanced Biotech start-ups in the field. Will Nestlé take control of the promising microbiome industry? Seres Health is a leading microbiome therapeutics platform company developing […]

January 9, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 6 Jan 2015

The largest VC investment in a single Biotech company has just been made

Wow, 2015 starts in a rush for the biotech industry. Moderna Therapeutics, Boston-based company led by French co-founding CEO Stephan Bancel just raised $450M (€380M) in VC investment. According to The Wall Street Journal, it is the largest VC-Investment ever made in a Biotech company. Moderna was founded only in 2011 and is an awesome company […]

January 6, 2015 - 1 minutemin - By Philip Hemme

News and Trends 20 Dec 2014

French Biotech Start-up Adocia signs Massive €464M Diabetes Deal with Eli Lilly

The French biotechnology company Adocia entered into an alliance with the US Eli Lilly on the co-development of an ultra-fast insulin to treat type 1 and type 2 diabetes. This insuline, called BioChaperone Lispro, has been developed through Adocia’s technology BioChaperone, is currently in Phase Ib clinical study. Under this global license agreement with Adocia, Eli Lilly […]

December 20, 2014 - 2 minutesmins - By Philip Hemme

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Philip Hemme

About

Articles by Philip Hemme

The Metamorphosis of Biopharmaceutical Innovation #BIO-Europe2015

The World’s First €100M Microbiome-focused Venture Fund opened in France

Sanofi and its Succesful Pivot from Chemistry to Biotechnology [BIO-Spring 2015]

Live from Bio-Europe 2015: The product development challenges in the gene therapy field

And now, Moderna signs a strategic partnership with prestigious Institut Pasteur

Is Gecko’s Bio-inspired Glue going to revolutionize Heart Surgery and Tissue Repair?

Will Microalgaes solve the Rare Earth conflict?

Qiagen, the new giant in next-gen sequencing tools?

Roche spent $1B for the Leading Molecular Information Biotech company: Foundation Medicine

Will Nestlé lead the promising microbiome industry?

The largest VC investment in a single Biotech company has just been made

French Biotech Start-up Adocia signs Massive €464M Diabetes Deal with Eli Lilly

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

About

Articles by Philip Hemme

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!